Actionable news
All posts from Actionable news
Actionable news in BMRN: BioMarin Pharmaceutical Inc.,

Here are Credit Suisse's top 3 biotech picks

Celgene (NASDAQ:CELG): Target $144. Implied upside 33%. "We believe that CELG looks cheap relative to its growth after reviewing current and pipeline products. We see more upside on base business products than consensus and guidance. We like Celgene’s pipeline that consists of internal and...